Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Standardized Treatment of Pulmonary Exacerbations II

ClinicalTrials.gov ID: NCT02781610

Public ClinicalTrials.gov record NCT02781610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Standardized Treatment of Pulmonary Exacerbations II (STOP2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Cystic fibrosis (CF), a life-shortening genetic disease, is marked by acute episodes during which symptoms of lung infection increase and lung function decreases. These pulmonary exacerbations are treated with varying antibiotics for varying time periods based on needs determined by individual patients, their families, and the health care providers. Cystic fibrosis pulmonary guidelines for the treatment of pulmonary exacerbation published by the Cystic Fibrosis Foundation (CFF) in 2009 provided recommendations for treatment and also identified key questions for which additional studies were needed. A strong desire among clinicians to reduce treatment durations (and reduce cost, inconvenience, and potential toxicities) is in conflict with belief that patients not responding robustly to treatment might benefit from extending treatment. This randomized, controlled, open-label study is designed to evaluate the efficacy and safety of differing durations of IV treatment, given in the hospital or at home for a pulmonary exacerbation in adult patients with CF.

Study identification

NCT ID
NCT02781610
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Chris Goss
Other
Enrollment
982 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2016 (Type not available)
Primary completion
Mar 6, 2020 (Actual)
Completion
Mar 6, 2020 (Actual)
Last update posted
May 19, 2021

2016 – 2020

United States locations

U.S. sites
57
U.S. states
30
U.S. cities
55
Facility City State ZIP Site status
The Children's Hospital Alabama Birmingham Alabama 35233 —
Providence Alaska Medical Center Anchorage Alaska 99519-6604 —
University Medical Center Tucson Arizona 85724 —
UC San Diego Medical Center La Jolla California 92037 —
Lucile S. Packard Children's Hospital Palo Alto California 94304 —
University of California Davis, Health System Sacramento California 95817 —
National Jewish Health Denver Colorado 80206 —
Hartford Hospital Hartford Connecticut 06106 —
Yale New Haven Hospital New Haven Connecticut 06520 —
Shands Hospital Gainesville Florida 32610 —
Joe DiMaggio Children's Hospital (Adult) Hollywood Florida 33021 —
University of Miami Miami Florida 33136 —
Emory University Hospital Atlanta Georgia 30322 —
Augusta University Medical Center Augusta Georgia 30912 —
St. Luke's Regional Medical Center Boise Idaho 83712 —
Saint Francis Medical Center Peoria Illinois 61603 —
Indiana University Hospital, Indiana University Health Indianapolis Indiana 46202 —
The University of Kansas Hospital Kansas City Kansas 66160 —
John Hopkins Hospital Baltimore Maryland 21205 —
Boston Children's Hospital (BCH) Boston Massachusetts 02115 —
University of Massachusetts Memorial Health Care (Worcester, MA) Worcester Massachusetts 01655 —
University of Michigan Health System Ann Arbor Michigan 48109-5212 —
Detroit Medical Center; Harper University Hospital Detroit Michigan 48201 —
Saint Louis University Hospital St Louis Missouri 63110 —
St. Louis Washington University Adult - Barnes-Jewish Hospital St Louis Missouri 63110 —
Billings Clinic Billings Montana 59107-7000 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Monmouth Medical Center Long Branch New Jersey 07740 —
Morristown Medical Center Morristown New Jersey 07960 —
Robert Wood Johnson University Hospital (New Brunswick, NJ) New Brunswick New Jersey 08903 —
Women and Children's Hospital of Buffalo Buffalo New York 14222 —
The Long Island Jewish Medical Center New Hyde Park New York 11040 —
Beth Israel Medical Center New York New York 10003 —
Columbia University Medical Center New York New York 10032 —
Highland Hospital; Strong Memorial Hospital Rochester New York 14642 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
New York Medical College Valhalla New York 10595 —
North Carolina Children's Hospital Chapel Hill North Carolina 27517 —
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157 —
Akron Children's Hospital Akron Ohio 44308 —
University Hospital of Cleveland Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Dayton Children's Hospital Dayton Ohio 45404 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina; Medical University of South Carolina Children's Hospital Charleston South Carolina 29425 —
University of Texas Southwestern Dallas Texas 75390 —
Baylor St. Lukes Medical Center Houston Texas 77030 —
University of Texas Health Center at Tyler Tyler Texas 75708-3154 —
The University of Vermont Medical Center Inc. Burlington Vermont 05401 —
University of Virginia Health System Charlottesville Virginia 22908 —
Medical College of Virginia (Richmond, VA) Richmond Virginia 23298 —
University of Washington Medical Center Seattle Washington 98195 —
Ruby Memorial Hospital Morgantown West Virginia 26506 —
University of Wisconsin Hospital Center Madison Wisconsin 53792 —
Froedtert Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02781610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2021 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02781610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →